en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
4/2021
vol. 59
 
Share:
Share:
more
 
 
abstract:
Original paper

Challenges of Egyptian patients with systemic lupus erythematosus during the COVID-19 pandemic

Samar Tharwat
1
,
Sherin Zohdy Mohamed
2
,
Mohammed Kamal Nassar
3

1.
Rheumatology and Immunology Unit, Department of Internal Medicine, Mansoura University, Faculty of Medicine, Egypt
2.
Department of Internal Medicine, Horus University, Faculty of Medicine, Egypt
3.
Mansoura Nephrology and Dialysis Unit, Department of Internal Medicine, Mansoura University, Faculty of Medicine, Egypt
Reumatologia 2021; 59, 4: 237–243
Online publish date: 2021/08/20
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The coronavirus disease 2019 (COVID-19) pandemic in Egypt is part of the worldwide COVID-19 pandemic that has contributed to substantial deterioration of healthcare systems. The aim of this study was to assess the challenges faced by Egyptian systemic lupus erythematosus (SLE) patients during the COVID-19 pandemic.

Material and methods
This questionnaire-based study was carried out on 200 patients with SLE from Egypt. The questionnaire provided covered socioeconomic status, lupus disease data, information about COVID-19 infection, and medical and family history of COVID-19 infection.

Results
The mean age of the participants was 30.1 ±8.4 years. 140/200 (70%) of the participants reported difficulty in obtaining medications during the COVID-19 pandemic, particularly antimala­rials (60%). The lupus disease condition became worse because of the drug shortage in half of the participants. Wearing protective masks (74%) and using disinfectants of the hands several times per day (67%) were the most reported used measures. Forty patients (20%) had to stop or reduce taking nonsteroidal anti-inflammatory drugs while 10 patients (5%) had to start taking antimalarials as a prophylaxis against COVID-19 infection. Among those who needed hospitalization, the main cause was lupus activity, and most of them (71%) experienced difficulty in hospital admission. Thirty-two patients (16%) had confirmed COVID-19 infection. About half of them had lupus flare and had to change the medications used for treatment of lupus.

Conclusions
The current COVID-19 pandemic has a negative impact on the healthcare provided to SLE patients in Egypt. Patients with SLE faced a shortage of their medications, especially antimala­rials, and difficulty in hospital admission.

keywords:

systemic lupus erythematosus, COVID-19, healthcare







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.